Track topics on Twitter Track topics that are important to you
Praveen Ramakrishnan, MD, spotlights some of the exciting data recently presented across the spectrum of non-Hodgkin lymphoma treatment.
Original Article: CAR T-Cell Products Among Top Advances in Non-Hodgkin LymphomaNEXT ARTICLE
Hodgkin Lymphoma is a disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...